U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401459) titled 'A Multimodal AI Agent for Ophthalmic Clinical Decision Support' on Nov. 17, 2025.
Brief Summary: This study is a multicenter randomized controlled trial evaluating the effectiveness and safety of EyeAgent, a multimodal artificial intelligence (AI) agent designed to assist ophthalmologists in clinical decision-making. Participants will be recruited from ophthalmology clinics and hospitals in Hong Kong and mainland China. The AI agent acts as a digital co-pilot, analyzing patient images and clinical history to provide diagnostic and management recommendations. The trial aims to determine whether the use of the AI agent improves diagno...